Cargando…

Oncogenic role of MiR-130a in oral squamous cell carcinoma

Aberrant activation of the PI3K/AKT/mTOR pathway is attributed to the pathogenesis of oral squamous cell carcinoma (OSCC). In recent years, increasing evidence suggests the involvement of microRNAs (miRNAs) in oral carcinogenesis by acting as tumor suppressors or oncogenes. TSC1, as a component of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallela, Karthik, Shivananda, Swamy, Gopinath, Kodaganur S., Kumar, Arun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032739/
https://www.ncbi.nlm.nih.gov/pubmed/33833339
http://dx.doi.org/10.1038/s41598-021-87388-4
_version_ 1783676272634757120
author Mallela, Karthik
Shivananda, Swamy
Gopinath, Kodaganur S.
Kumar, Arun
author_facet Mallela, Karthik
Shivananda, Swamy
Gopinath, Kodaganur S.
Kumar, Arun
author_sort Mallela, Karthik
collection PubMed
description Aberrant activation of the PI3K/AKT/mTOR pathway is attributed to the pathogenesis of oral squamous cell carcinoma (OSCC). In recent years, increasing evidence suggests the involvement of microRNAs (miRNAs) in oral carcinogenesis by acting as tumor suppressors or oncogenes. TSC1, as a component of the above pathway, regulates several cellular functions such as cell proliferation, apoptosis, migration and invasion. Downregulation of TSC1 is reported in oral as well as several other cancers and is associated with an unfavourable clinical outcome in patients. Here we show that oncogenic miR-130a binds to the 3′UTR of TSC1 and represses its expression. MiR-130a-mediated repression of TSC1 increases cell proliferation, anchorage independent growth and invasion of OSCC cells, which is dependent on the presence of the 3′UTR in TSC1. We observe an inverse correlation between the expression levels of miR-130a and TSC1 in OSCC samples, suggesting that their interaction is physiologically relevant. Delivery of antagomiR-130a to OSCC cells results in a significant decrease in xenograft size. Taken together, the findings of the study indicate that miR-130a-mediated TSC1 downregulation is not only a novel mechanism in OSCC, but also the restoration of TSC1 levels by antagomiR-130a may be a potential therapeutic strategy for the treatment of OSCC.
format Online
Article
Text
id pubmed-8032739
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-80327392021-04-09 Oncogenic role of MiR-130a in oral squamous cell carcinoma Mallela, Karthik Shivananda, Swamy Gopinath, Kodaganur S. Kumar, Arun Sci Rep Article Aberrant activation of the PI3K/AKT/mTOR pathway is attributed to the pathogenesis of oral squamous cell carcinoma (OSCC). In recent years, increasing evidence suggests the involvement of microRNAs (miRNAs) in oral carcinogenesis by acting as tumor suppressors or oncogenes. TSC1, as a component of the above pathway, regulates several cellular functions such as cell proliferation, apoptosis, migration and invasion. Downregulation of TSC1 is reported in oral as well as several other cancers and is associated with an unfavourable clinical outcome in patients. Here we show that oncogenic miR-130a binds to the 3′UTR of TSC1 and represses its expression. MiR-130a-mediated repression of TSC1 increases cell proliferation, anchorage independent growth and invasion of OSCC cells, which is dependent on the presence of the 3′UTR in TSC1. We observe an inverse correlation between the expression levels of miR-130a and TSC1 in OSCC samples, suggesting that their interaction is physiologically relevant. Delivery of antagomiR-130a to OSCC cells results in a significant decrease in xenograft size. Taken together, the findings of the study indicate that miR-130a-mediated TSC1 downregulation is not only a novel mechanism in OSCC, but also the restoration of TSC1 levels by antagomiR-130a may be a potential therapeutic strategy for the treatment of OSCC. Nature Publishing Group UK 2021-04-08 /pmc/articles/PMC8032739/ /pubmed/33833339 http://dx.doi.org/10.1038/s41598-021-87388-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Mallela, Karthik
Shivananda, Swamy
Gopinath, Kodaganur S.
Kumar, Arun
Oncogenic role of MiR-130a in oral squamous cell carcinoma
title Oncogenic role of MiR-130a in oral squamous cell carcinoma
title_full Oncogenic role of MiR-130a in oral squamous cell carcinoma
title_fullStr Oncogenic role of MiR-130a in oral squamous cell carcinoma
title_full_unstemmed Oncogenic role of MiR-130a in oral squamous cell carcinoma
title_short Oncogenic role of MiR-130a in oral squamous cell carcinoma
title_sort oncogenic role of mir-130a in oral squamous cell carcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032739/
https://www.ncbi.nlm.nih.gov/pubmed/33833339
http://dx.doi.org/10.1038/s41598-021-87388-4
work_keys_str_mv AT mallelakarthik oncogenicroleofmir130ainoralsquamouscellcarcinoma
AT shivanandaswamy oncogenicroleofmir130ainoralsquamouscellcarcinoma
AT gopinathkodaganurs oncogenicroleofmir130ainoralsquamouscellcarcinoma
AT kumararun oncogenicroleofmir130ainoralsquamouscellcarcinoma